The potential danger of COX-2 inhibitors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (4)

• Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study via openalex
• W1984374883 via openalex
• W2085052924 via openalex
• W2145858946 via openalex

Cited by (10)

• Ovulation: A consequence of acute inflammation cultivated by E2-induced reactive oxygen species and triggered by progesterone withdrawal 2025
• Relationship between the change of ATP level controlled by ectonucleotidases and endometriosis-associated infertility and pain 2024
• Unveiling the therapeutic mechanisms of taraxasterol from dandelion in endometriosis: Network pharmacology and cellular insights 2024
• The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis 2023
• The Endometriosis - treatment and new methods 2023
• Changing prostaglandin E2 (PGE₂) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE₂ receptor EP2 and EP4 2021
• Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
• Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model 2008
• Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells 2007
• Non-steroidal anti-inflammatory drugs (NSAIDs) and ovulation: lessons from morphology. 2006

Source provenance

openalex

last seen: 2026-06-04T00:00:01.174412+00:00